UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 13, 2003
IMMUNOMEDICS, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-12104 61-1009366
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
300 American Road, Morris Plains, New Jersey 07950
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: (973) 605-8200
Not applicable
(Former name or former address, if changed since last report)
Item 7. Financial Statements and Exhibits
(c) Exhibits
99.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter
63 of Title 18, United States Code), dated February 13, 2003.
Item 9. Regulation FD Disclosure
On February 13, 2003, the Registrant filed its Quarterly Report on Form
10-Q for the quarter ended December 31, 2002 with the Securities and Exchange
Commission. In connection with the filing of the Form 10-Q, attached hereto as
an exhibit are certifications of the Registrant's Chief Executive Officer and
Chief Financial Officer, as required by 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. These certifications
are being furnished herewith solely to accompany the Form 10-Q, pursuant to 18
U.S.C. Section 1350, are not being filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, and are not to be incorporated by
reference into any of the Registrant's filings with the Securities and Exchange
Commission, whether filed prior to or after the furnishing of these
certifications, regardless of any general or specific incorporation language in
any such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMMUNOMEDICS, INC.
Date: February 13, 2003 /s/ Cynthia L. Sullivan
-----------------------
Cynthia L. Sullivan
President and Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
Number Description
------- -----------
99.1 Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title
18, United States Code), dated February 13, 2003.
4